Shares of Intuitive Surgical (NASDAQ: ISRG) climbed 7.6% during the afternoon trading session following the release of robust first-quarter 2026 financial results that significantly surpassed analyst projections. The company reported quarterly revenue of $2.77 billion, representing a 23% year-over-year increase that exceeded consensus estimates by...
Intuitive Surgical Director Amy Ladd sold 72 shares of the company's stock on August 11th under a pre-arranged Rule 10b5-1 trading plan. The transaction averaged $393.10 per share, totaling approximately $28,303, leaving her with 179 shares valued at roughly $70,365. This sale represents a 28.69%...
Intuitive Surgical (NASDAQ:ISRG) shares experienced a significant gap down, opening at $365.03 after closing the previous session at $402.33. This decline was primarily triggered by JPMorgan Chase lowering its price target from $550.00 to $450.00, despite maintaining an overweight rating on the stock. The immediate...
Institutional ownership of Intuitive Surgical, Inc. (NASDAQ:ISRG) saw mixed activity in the first quarter, with AMF Tjanstepension AB reducing its stake by 19.4% to 171,089 shares valued at $78.87 million. Conversely, several other major funds increased their positions significantly, including Teachers Retirement System of Kentucky...
Intuitive Surgical has introduced the EndoWrist Stapler 45, a single-patient-use robotic stapling instrument designed for its da Vinci Xi and X systems. This new accessory enables wristed articulation and integrated software confirmation for clamp and firing conditions, specifically targeting complex colorectal and thoracic procedures such...
